Autolus Therapeutics delays Q1 2024 filing; cancels May 14 earnings call, reschedules to May 17

Autolus Therapeutics plc

Plans to file Form 12b-25 for automatic 5-day extension of Q1 2024 10-Q due May 15.
Cancels previously announced earnings call scheduled for May 14, 2024.
Reschedules Q1 2024 conference call and webcast to May 17, 2024 at 8:30 am EDT.
Expects to file Q1 10-Q no later than May 20, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.